Kv1.3 channels as a potential target for immunomodulation of CD4 +CD28 null T cells in patients with acute coronary syndrome

Clinical Immunology

Volumn 142, Issue 2, 2012, Pages 209-217

  Xu, Rende ^a   Cao, Ming ^a   Wu, Xiaofen ^a   Wang, Xingfen ^a   Ruan, Lei ^a   Quan, Xiaoqing ^a   Lü, Caixia ^a   He, Wei ^a   Zhang, Cuntai ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Acute coronary syndrome; CD4 +CD28 null T cell; K + channel

Indexed keywords

CALCIUM CHANNEL; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; CHEMOKINE RECEPTOR CCR7; FLUORESCEIN ISOTHIOCYANATE; GAMMA INTERFERON; PERFORIN; POTASSIUM CHANNEL KV1.3;

ACUTE CORONARY SYNDROME; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOMODULATION; ION CONDUCTANCE; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACUTE CORONARY SYNDROME; AGED; ANTIGENS, CD28; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FICUSIN; HUMANS; IMMUNOMODULATION; INTERFERON-GAMMA; KV1.3 POTASSIUM CHANNEL; MALE; MIDDLE AGED; PERFORIN; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; T-LYMPHOCYTE SUBSETS;

EID: 84856550894     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2011.10.009     Document Type: Article

References (25)

1. Lopez A.D., Mathers C.D., Ezzati M., Jamison D.T., Murray C.J. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006, 367:1747-1757.
2. Klingenberg R., Hansson G.K. Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies. Eur. Heart J. 2009, 30:2838-2844.
3. G.J, Weyand C.M., Liuzzo G., Kopecky S.L., Holmes D.R., Frye R.L. T-cell immunity in acute coronary syndromes. Mayo Clin. Proc. 2001, 76:1011-1020.
4. Gotsman I., Sharpe A.H., Lichtman A.H. T-cell costimulation and coinhibition in atherosclerosis. Circ. Res. 2008, 103:1220-1231.
5. G.J, Liuzzo G., Yang H., Kopecky S.L., Holmes D.R., Frye R.L., Weyand C.M. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 2000, 101:2883-2888.
6. Huang S., Tang J.R., Zhang C.T., Sun L.P., Guo L.F., Sun M. Upregulated voltage-gated potassium channel Kv1.3 on the CD4+CD28null T lymphocyte from patients with acute coronary syndrome. Zhonghua Xin Xue Guan Bing Za Zhi 2008, 36:602-607.
7. Weyand C.M., Brandes J.C., Schmidt D., Fulbright J.W., Goronzy J.J. Functional properties of CD4+ CD28- T cells in the aging immune system. Mech. Ageing Dev. 1998, 102:131-147.
8. G.O, Nakajima T., Zhang X., Kopecky S.L., Frye R.L., Goronzy J.J., Weyand C.M. De novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes. Circ. Res. 2003, 93:106-113.
9. A.E, Dumitriu I.E., Baboonian C., Kaski J.C. CD4+CD28null T cells in coronary artery disease: when helpers become killers. Cardiovasc. Res. 2009, 81:11-19.
10. Beeton C., Wulff H., Standifer N.E., Azam P., Mullen K.M., Pennington M.W., Kolski-Andreaco A., Wei E., Grino A., Counts D.R., Wang P.H., LeeHealey C.J., S.A.B, Sankaranarayanan A., Homerick D., Roeck W.W., Tehranzadeh J., Stanhope K.L., Zimin P., Havel P.J., Griffey S., Knaus H.G., Nepom G.T., Gutman G.A., Calabresi P.A., Chandy K.G. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:17414-17419.
11. Lewis R.S., Cahalan M.D. Potassium and calcium channels in lymphocytes. Annu. Rev. Immunol. 1995, 13:623-653.
12. Wulff Heike, Calabresi Peter A., Allie Rameeza, Yun Sung, Pennington Michael, Beeton Christine, Chandy K.G. The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS. J. Clin. Invest. 2003, 111:1703-1713.
13. Beeton C., Wulff H., Barbaria J., Clot-Faybesse O., Pennington M., Bernard D., Cahalan M.D., Chandy K.G., Beraud E. Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:13942-13947.
14. Desir G.V. Kv1.3 potassium channel blockade as an approach to insulin resistance. Expert Opin. Ther. Targets 2005, 9:571-579.
15. Grissmer S., Dethlefs B., Wasmuth J.J., Goldin A.L., Gutman G.A., Cahalan M.D., Chandy K.G. Expression and chromosomal localization of a lymphocyte K+ channel gene. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:9411-9415.
16. Ghanshani S., Wulff H., Miller M.J., Rohm H., Neben A., Gutman G.A., Cahalan M.D., Chandy K.G. Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences. J. Biol. Chem. 2000, 275:37137-37149.
17. Alegre M.L., Frauwirth K.A., Thompson C.B. T-cell regulation by CD28 and CTLA-4. Nat. Rev. Immunol. 2001, 1:220-228.
18. Morishita Y., Sao H., Hansen J.A., Martin P.J. A distinct subset of human CD4+ cells with a limited alloreactive T cell receptor repertoire. J. Immunol. 1989, 143:2783-2789.
19. + channels as targets for specific immunomodulation. Trends Pharmacol. Sci. 2004, 25:280-289.
20. Shiao S.L., Kirkiles-Smith N.C., Shepherd B.R., McNiff J.M., Carr E.J., Pober J.S. Human effector memory CD4+ T cells directly recognize allogeneic endothelial cells in vitro and in vivo. J. Immunol. 2007, 179:4397-4404.
21. Martens P.B., Goronzy J.J., Schaid D., Weyand C.M. Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. Arthritis Rheum. 1997, 40:1106-1114.
22. Markovic-Plese S., Cortese I., Wandinger K.P., McFarland H.F., Martin R. CD4+CD28- costimulation-independent T cells in multiple sclerosis. J. Clin. Invest. 2001, 108:1185-1194.
23. Schmitz A., Sankaranarayanan A., Azam P., Schmidt-Lassen K., Homerick D., Hansel W., Wulff H. Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases. Mol. Pharmacol. 2005, 68:1254-1270.
24. Pereira L.E., Villinger F., Wulff H., Sankaranarayanan A., Raman G., Ansari A.A. Pharmacokinetics, toxicity, and functional studies of the selective Kv1.3 channel blocker 5-(4-phenoxybutoxy)psoralen in rhesus macaques. Exp. Biol. Med. (Maywood) 2007, 232:1338-1354.
25. Matheu M.P., Beeton C., Garcia A., Chi V., Rangaraju S., Safrina O., Monaghan K., Uemura M.I., Li D., Pal S., de la Maza L.M., Monuki E., Flugel A., Pennington M.W., Parker I., Chandy K.G., Cahalan M.D. Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block. Immunity 2008, 29:602-614.